FDR works with over 300 companies, research institutions and investors in the life sciences located throughout the United States, Japan and Europe. The following list is representative of the kinds of clients we serve.
Exclusive Life Sciences Focus
Drug Discovery/Development
- Acetylon Pharmaceuticals
- Agios Pharmaceuticals
- Alnylam Pharmaceuticals
- Biovex
- Catabasis Pharmaceuticals
- Cougar Biotechnology
- Dyax
- Edimer Pharmaceuticals
- Eisai
- Epizyme
- Lux Biosciences
- Ophthotech
- Pharmasset
- Portola Pharmaceuticals
- PTC Therapeutics
- RXi Pharmaceuticals
- Seaside Therapeutics
- Solasia Pharma
- Stromedix
- Synedgen
- Taligen Therapeutics
- Xenome
- Access Pharmaceuticals
- Cubist Pharmaceuticals
- Endo Pharmaceuticals
- Laboratoire HRA Pharma
- Millennium The Takeda Oncology Company
- Mutual Pharmaceutical Company
- Sepracor
- Shire Pharmaceuticals
Medical Devices, Diagnostics, Materials & Tools
- AgaMatrix
- Cambridge Polymer Group
- Flex Biomedical
- Foundation Medicine
- Genstruct
- Ikonisys
- Immuneering
- Modular Genetics
- PerkinElmer
- RainDance Technologies
- Schrödinger
- Scil Technology
- SmartCells
- Xemed
- Evogene
- Martek Biosciences
- Mendel Biotechnology
- Clinical Trial Solutions
- Genexion
- Hovione
- Medichem
Venture Capital & Private Equity
- Abingworth Management
- Atlas Venture
- Endurance Investments
- Lakeview Capital Management
- Latin America Pharma
- Lux Capital Management
- Novo A/S
- Third Rock Ventures
- Trevi Health Ventures
- Academic Partners for Medical Education
- CAVU Foundation
- CFRx
- Children's Hospital Boston
- Harvard University
- Tufts University
- Yissum – Hebrew University (Jerusalem)